United States Food & Drug Retailing

Guardian Pharmacy Services Inc (GRDN)

Track

Ticker: GRDN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Guardian Pharmacy Services Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 20 Mar 2026
Value US$4,515,167.85 | Price 388.77 | Shares 59,398 (-49.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-24 2026-03-20 S Sale
0.7
Cardinal Equity Fund, L.P.

Member of 10% owner group
59,398 -49.3%
388.77
US$4,515,168 		59,398 -49.3% 388.77 US$4,515,168
2026-03-24 2026-03-20 S Sale
0.7
Pharmacy Investors, LLC

Member of 10% owner group
72,056 +10.3%
188.94
US$27,002 		72,056 +10.3% 188.94 US$27,002
2026-03-24 2026-03-20 S Sale
0.7
Morris David K

See Remarks

Executive Director
38,101 +19.7%
424.42
US$3,257,465 		38,101 +19.7% 424.42 US$3,257,465
2026-03-24 2026-03-20 S Sale
0.7
Burke Fred

See Remarks

Executive Director
671,432 -44.4%
29.68
US$19,929,780 		671,432 -44.4% 29.68 US$19,929,780
2026-03-24 2026-03-20 S Sale
0.7
Forbes Kendall

See Remarks

Officer
346,672 -43.3%
29.68
US$10,290,092 		346,672 -43.3% 29.68 US$10,290,092
2026-03-24 2026-03-20 S Sale
0.7
Bindley Capital Partners I, LLC
Large shareholder
3,570,677 -44.4%
29.68
US$105,986,620 		3,570,677 -44.4% 29.68 US$105,986,620
2026-03-24 2026-03-20 S Sale
0.7
Ackerman John
Non-Executive Director
275,728 -44.4%
29.68
US$8,184,296 		275,728 -44.4% 29.68 US$8,184,296
2026-03-24 2026-03-20 S Sale
0.7
Ackerman John
Non-Executive Director
827,636 -44.4%
29.68
US$24,566,306 		827,636 -44.4% 29.68 US$24,566,306
2026-03-24 2026-03-20 S Sale
0.7
BINDLEY WILLIAM E
Non-Executive Director Large shareholder
3,570,677 -44.4%
29.68
US$105,986,620 		3,570,677 -44.4% 29.68 US$105,986,620
2026-03-24 2026-03-20 S Sale
0.7
Salentine Thomas J Jr
Non-Executive Director Large shareholder
3,570,677 -44.4%
29.68
US$105,986,620 		3,570,677 -44.4% 29.68 US$105,986,620
2025-12-05 2025-12-03 B Purchase
2.8
COSLER STEVEN D
Non-Executive Director
3,370 +15.6%
29.61
US$99,786 		3,370 +15.6% 29.61 US$99,786
2025-09-30 2025-05-28 S Sale
0.7
Pharmacy Investors, LLC

Member of 10% owner group
150,998 -25.1%
20.16
US$3,044,120 		150,998 -25.1% 20.16 US$3,044,120
2025-09-30 2025-05-28 S Sale
0.7
Cardinal Equity Fund, L.P.

Member of 10% owner group
50,305 -25.1%
20.16
US$1,014,149 		50,305 -25.1% 20.16 US$1,014,149
2025-05-29 2025-05-28 S Sale
0.7
Morris David K

See Remarks

Executive Director
68,547 -24.2%
20.16
US$1,381,908 		68,547 -24.2% 20.16 US$1,381,908
2025-05-29 2025-05-28 S Sale
0.7
Forbes Kendall

See Remarks

Officer
64,991 -24.2%
20.16
US$1,310,219 		64,991 -24.2% 20.16 US$1,310,219
2025-05-29 2025-05-28 S Sale
0.7
BINDLEY WILLIAM E
Non-Executive Director Large shareholder
651,454 -25.1%
20.16
US$13,133,313 		651,454 -25.1% 20.16 US$13,133,313
2025-05-29 2025-05-28 S Sale
0.7
Burke Fred

See Remarks

Executive Director
138,705 -25.1%
20.16
US$2,796,293 		138,705 -25.1% 20.16 US$2,796,293
2025-05-29 2025-05-28 S Sale
0.7
Salentine Thomas J Jr
Non-Executive Director Large shareholder
651,454 -25.1%
20.16
US$13,133,313 		651,454 -25.1% 20.16 US$13,133,313
2025-05-29 2025-05-28 S Sale
0.7
Ackerman John
Non-Executive Director
50,305 -25.1%
20.16
US$1,014,149 		50,305 -25.1% 20.16 US$1,014,149
2025-05-29 2025-05-28 S Sale
0.7
Ackerman John
Non-Executive Director
150,998 -25.1%
20.16
US$3,044,120 		150,998 -25.1% 20.16 US$3,044,120
2025-05-29 2025-05-28 S Sale
0.7
Bindley Capital Partners I, LLC
Large shareholder
651,454 -25.1%
20.16
US$13,133,313 		651,454 -25.1% 20.16 US$13,133,313
2025-09-30 2025-05-27 S Sale
0.7
Pharmacy Investors, LLC

Member of 10% owner group
813,318 -57.5%
20.16
US$16,396,491 		813,318 -57.5% 20.16 US$16,396,491
2025-09-30 2025-05-27 S Sale
0.7
Cardinal Equity Fund, L.P.

Member of 10% owner group
270,958 -57.5%
20.16
US$5,462,513 		270,958 -57.5% 20.16 US$5,462,513
2025-05-29 2025-05-27 S Sale
0.7
Morris David K

See Remarks

Executive Director
369,212 -56.6%
20.16
US$7,443,314 		369,212 -56.6% 20.16 US$7,443,314
2025-05-29 2025-05-27 S Sale
0.7
Forbes Kendall

See Remarks

Officer
350,058 -56.6%
20.16
US$7,057,169 		350,058 -56.6% 20.16 US$7,057,169
2025-05-29 2025-05-27 S Sale
0.7
BINDLEY WILLIAM E
Non-Executive Director Large shareholder
3,508,905 -57.5%
20.16
US$70,739,525 		3,508,905 -57.5% 20.16 US$70,739,525
2025-05-29 2025-05-27 S Sale
0.7
Burke Fred

See Remarks

Executive Director
747,102 -57.5%
20.16
US$15,061,576 		747,102 -57.5% 20.16 US$15,061,576
2025-05-29 2025-05-27 S Sale
0.7
Salentine Thomas J Jr
Non-Executive Director Large shareholder
3,508,905 -57.5%
20.16
US$70,739,525 		3,508,905 -57.5% 20.16 US$70,739,525
2025-05-29 2025-05-27 S Sale
0.7
Ackerman John
Non-Executive Director
270,958 -57.5%
20.16
US$5,462,513 		270,958 -57.5% 20.16 US$5,462,513
2025-05-29 2025-05-27 S Sale
0.7
Ackerman John
Non-Executive Director
813,318 -57.5%
20.16
US$16,396,491 		813,318 -57.5% 20.16 US$16,396,491
2025-05-29 2025-05-27 S Sale
0.7
Bindley Capital Partners I, LLC
Large shareholder
3,508,905 -57.5%
20.16
US$70,739,525 		3,508,905 -57.5% 20.16 US$70,739,525
2024-11-20 2024-11-19 B Purchase
2.8
COSLER STEVEN D
Non-Executive Director
7,000 +65.3%
21.22
US$148,540 		7,000 +65.3% 21.22 US$148,540
2024-10-01 2024-09-27 B Purchase
0.7
Salentine Thomas J Jr
Non-Executive Director
35,714 +inf%
14.00
US$499,996 		35,714 +inf% 14.00 US$499,996
2024-10-01 2024-09-27 B Purchase
2.8
COSLER STEVEN D
Non-Executive Director
7,142 +inf%
14.00
US$99,988 		7,142 +inf% 14.00 US$99,988
2024-10-01 2024-09-27 B Purchase
Patchett Mary Sue
Non-Executive Director
3,571 +inf%
14.00
US$49,994 		3,571 +inf% 14.00 US$49,994
2024-10-01 2024-09-27 B Purchase
3.8
LEWIS RANDALL J
Non-Executive Director
3,571 +inf%
14.00
US$49,994 		3,571 +inf% 14.00 US$49,994
Explore more

More insider trading research around Guardian Pharmacy Services Inc

More insider trades in United States
Similar Consumer Non-Cyclicals companies with insider activity
More Food & Drug Retailing companies with insider activity
More Food & Drug Retailing companies with insider activity
Insider trading in North America